Thoracic oncology
State of the art session
Thoracic oncology
Clinical
Unravelling lung cancer mazes: a call for an aggressive approach
Aims : to highlight the latest developments and controversies in lung cancer management; to cover four key areas in which critical new observations have been made in the past year; to provide consolidated updates in order to improve clinical management of lung cancer patients.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Medical Technical Assistant, Nurse, Respiratory critical care physician, Pathologist, Patient, Physician in Pulmonary Training, Physiologist, Radiologist, Respiratory physiotherapist, Scientist (basic, translational), Thoracic oncologist, Thoracic surgeon, Respiratory therapist, Journalist
Methods :
Cell and molecular biology, Palliative care, Surgery
11:15
Patient's testimony
S. Cotter(Clarecastle, Ireland)
COI
1
724
11:20
Does aggressive surgical management of oligometastatic disease pay off?
S. Elia(Roma (RM), Italy)
COI
-
Description
2
725
11:35
Recent advances in novel targeted therapies for non-small cell lung cancer and implications for current practice
J. van Meerbeeck(Edegem (Antwerp), Belgium)
COI
-
Description
3
726
11:50
Incorporating immunotherapy in early-stage lung cancer management
J. Chorostowska-Wynimko(Warsaw, Poland)
COI
-
Description
4
727
12:05
Dyspnoea management in lung cancer: Pandora's box?
I. Higginson(London, United Kingdom)
COI
-
Description
5
728
12:20
Discussion and Q&A
6
729
. . .
